Edgemoor Investment Advisors, Inc.
Position in TMO — Thermo Fisher Scientific Inc.
CIK 1313792
BETHESDA, MD
Position in TMO
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$8,870,061
-$19,259 QoQ
Shares Held
17,692
-2.2% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.63%
of 13F equity value
Holder Rank
#672
of 2,606 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Edgemoor Investment Advisors, Inc. holds $10,205,135 across 2 Diagnostics & Research names. TMO ranks #1 (86.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
This page
|
17,692 | $8,870,061 | |
| 2 | DHR |
Danaher Corp /De/
|
7,009 | $1,335,074 |
All Filings in TMO
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,870,061 | 17,692 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $8,889,320 | 18,085 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $10,007,680 | 17,271 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $8,392,301 | 17,303 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $9,294,765 | 22,924 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $9,067,267 | 18,222 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $9,567,549 | 18,391 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $11,578,393 | 18,718 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $10,281,929 | 18,593 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $10,336,238 | 17,784 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $8,316,948 | 15,669 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $6,867,714 | 13,568 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $7,994,775 | 15,323 | Shares | Sole | 2023-08-09 | |
| No filing history on record for this holder in this stock. | ||||||